Publicacións en colaboración con investigadores/as de Swiss Federal Institute of Technology in Zurich (16)

2009

  1. Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response

    Journal of Drug Targeting, Vol. 17, Núm. 8, pp. 652-661

  2. Nanoparticles for nasal vaccination

    Advanced Drug Delivery Reviews, Vol. 61, Núm. 2, pp. 140-157

  3. Optimization strategies for electrospun silk fibroin tissue engineering scaffolds

    Biomaterials, Vol. 30, Núm. 17, pp. 3058-3067

  4. Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering

    Biomaterials, Vol. 30, Núm. 28, pp. 5068-5076

2008

  1. A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles (Pharmaceutical Research DOI: 10.1007/s11095-007-9318-0)

    Pharmaceutical Research

  2. Dendronised block copolymers as potential vectors for gene transfection

    Organic and Biomolecular Chemistry, Vol. 6, Núm. 11, pp. 1905-1911

  3. Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis

    Journal of Controlled Release, Vol. 130, Núm. 2, pp. 161-167

  4. The effect of hyaluronic acid on silk fibroin conformation

    Biomaterials, Vol. 29, Núm. 6, pp. 633-642

2007

  1. A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles

    Pharmaceutical Research, Vol. 24, Núm. 10, pp. 1927-1935

  2. Cell response on silk fibroin scaffolds with varying topographies

    European Cells and Materials

  3. Glycopolymer-engineered biodegradable microparticles as vaccine against Leishmaniasis

    European Cells and Materials

  4. IGF-I time-concentration profiles can modulate the early stage differentiation of human mesenchymal stem cells: Application to ligament or cartilage engineering

    European Cells and Materials

  5. PLL-g-PEG/PEG-mannose functionalized nanogels for cell-receptortargeted drug delivery application

    European Cells and Materials

  6. Surface modified microparticles as carriers for nucleic acid vaccines and immunopotentiators

    European Cells and Materials

2006

  1. The performance of nanocarriers for transmucosal drug delivery

    Expert Opinion on Drug Delivery, Vol. 3, Núm. 4, pp. 463-478

2005

  1. Design of surface-modified lipid nanostructures for oral calcitonin delivery

    European Cells and Materials